Mitochondrial Intermediate Peptidase (MIPEP) (Middle Region) Peptid
MIPEP
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle MIPEP Produkte
- MIPEP (Mitochondrial Intermediate Peptidase (MIPEP))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- MKLNPQNSEV MPWDPPYYSG VIRAERYNIE PSLYCPFFSL GACMEGLNIL
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- MIPEP Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MIPEP (Mitochondrial Intermediate Peptidase (MIPEP))
- Hintergrund
-
The product of this gene performs the final step in processing a specific class of nuclear-encoded proteins targeted to the mitochondrial matrix or inner membrane. This protein is primarily involved in the maturation of oxidative phosphorylation (OXPHOS)-related proteins. This gene may contribute to the functional effects of frataxin deficiency and the clinical manifestations of Friedreich ataxia.
Alias Symbols: MIP, HMIP
Protein Size: 713 - Gen-ID
- 4285
- NCBI Accession
- NM_005932, NP_005923
- UniProt
- Q99797
-
Sie sind hier:
